Macquarie Bank Limited Publication of Second Supplementary Prospectus (3048N)

TIDM14WT

RNS Number : 3048N

Macquarie Bank Limited

22 September 2023

Announcement

Publication of Prospectus Supplement

The following prospectus supplement (the Supplement) has been approved by the Financial Conduct Authority and is available for viewing:

Macquarie Bank Limited (MBL) Supplement dated 21 September 2023 to the AUD 10,000,000,000 MBL Covered Bond Programme prospectus dated 9 June 2023 (the Prospectus)

To view the full document, please paste the following URL into the address bar of your browser.

https://www.macquarie.com/au/en/investors/debt-investors/secured-funding.html

A copy of the Supplement has also been submitted to the National Storage Mechanism and will shortly be available

for inspection at:   https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

For further information, please contact:

Macquarie Bank Limited

Mr. Angus Cameron

Level 6, No.50 Martin Place

Sydney NSW 2000

Australia

Telephone : [phone]

Fax : [phone]

Email: [e-mail]

DISCLAIMER -- INTENDED ADDRESSEES

Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus, as supplemented, is not addressed. Prior to relying on the information contained in the Prospectus, as supplemented, you must ascertain from the Prospectus, as supplemented, whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPFIFIVAEIFFIV

(END) Dow Jones Newswires

September 22, 2023 02:00 ET (06:00 GMT)